ENTRY       D02561                      Drug
NAME        Moclobemide (USAN/INN);
            Aurorix (TN)
FORMULA     C13H17ClN2O2
EXACT_MASS  268.0979
MOL_WEIGHT  268.7393
CLASS       Neuropsychiatric agent
             DG01568  MAO inhibitor
              DG01558  Monoamine oxidase A inhibitor
            Metabolizing enzyme substrate
             DG01639  CYP2C19 substrate
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      ATC code: N06AG02
EFFICACY    Antidepressant, Monoamine oxidase A (MAO-A) inhibitor
TARGET      MAOA [HSA:4128] [KO:K00274]
  PATHWAY   hsa00260(4128)  Glycine, serine and threonine metabolism
            hsa00330(4128)  Arginine and proline metabolism
            hsa00340(4128)  Histidine metabolism
            hsa00350(4128)  Tyrosine metabolism
            hsa00360(4128)  Phenylalanine metabolism
            hsa00380(4128)  Tryptophan metabolism
            hsa00982(4128)  Drug metabolism - cytochrome P450
            hsa04726(4128)  Serotonergic synapse
            hsa04728(4128)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2C19 [HSA:1557]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565], CYP2C19 [HSA:1557]
STR_MAP     map07027  Antidepressants
            map07216  Catecholamine transferase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AG Monoamine oxidase A inhibitors
                 N06AG02 Moclobemide
                  D02561  Moclobemide (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01558  Monoamine oxidase A inhibitor
                D02561  Moclobemide
             Metabolizing enzyme substrate
              DG01639  CYP2C19 substrate
               D02561  Moclobemide
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               D02561  Moclobemide
              DG01645  CYP2D6 inhibitor
               D02561  Moclobemide
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Amine oxidases
                MAOA
                 D02561  Moclobemide (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02561
DBLINKS     CAS: 71320-77-9
            PubChem: 17396732
            ChEBI: 83531
            LigandBox: D02561
            NIKKAJI: J19.047K
ATOM        18
            1   C8x C    11.9700  -17.9200
            2   C8y C    11.9700  -19.3200
            3   C8x C    13.1824  -20.0200
            4   C8x C    14.3949  -19.3200
            5   C8y C    14.3949  -17.9200
            6   C8x C    13.1824  -17.2200
            7   X   Cl   10.7576  -20.0200
            8   C5a C    15.6260  -17.2090
            9   N1b N    16.8312  -17.9047
            10  O5a O    15.6257  -15.8201
            11  C1b C    18.0135  -17.2219
            12  C1b C    19.2075  -17.9112
            13  N1y N    20.3954  -17.2252
            14  C1x C    21.5865  -17.9129
            15  C1x C    22.7990  -17.2129
            16  O2x O    22.7990  -15.8129
            17  C1x C    21.6079  -15.1252
            18  C1x C    20.3955  -15.8252
BOND        19
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     2   7 1
            8     5   8 1
            9     8   9 1
            10    8  10 2
            11    9  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   13  18 1
///
